医疗保健数据库中的无假设信号检测：探寻其在药物警戒中的价值。 - Suppr

Hypothesis-free signal detection in healthcare databases: finding its value for pharmacovigilance.

作者信息

Bate Andrew, Hornbuckle Ken, Juhaeri Juhaeri, Motsko Stephen P, Reynolds Robert F

机构信息

Division of Translational Medicine, Department of Medicine, NYU School of Medicine, 462 1st Avenue, NY10016, New York, USA.

Global Patient Safety, Eli Lilly and Company, Indianapolis, IN, USA.

出版信息

Ther Adv Drug Saf. 2019 Aug 5;10:2042098619864744. doi: 10.1177/2042098619864744. eCollection 2019.

DOI:10.1177/2042098619864744

PMID:31428307

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6683315/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2633/6683315/ba1e416bb8b7/10.1177_2042098619864744-fig1.jpg

相似文献

Hypothesis-free signal detection in healthcare databases: finding its value for pharmacovigilance.

Ther Adv Drug Saf. 2019 Aug 5;10:2042098619864744. doi: 10.1177/2042098619864744. eCollection 2019.

Using real-world healthcare data for pharmacovigilance signal detection - the experience of the EU-ADR project.

Expert Rev Clin Pharmacol. 2015 Jan;8(1):95-102. doi: 10.1586/17512433.2015.992878.

Time Series Disturbance Detection for Hypothesis-Free Signal Detection in Longitudinal Observational Databases.

Drug Saf. 2018 Jun;41(6):565-577. doi: 10.1007/s40264-018-0640-8.

Early detection of pharmacovigilance signals with automated methods based on false discovery rates: a comparative study.

Drug Saf. 2012 Jun 1;35(6):495-506. doi: 10.2165/11597180-000000000-00000.

Benefits of combining change-point analysis with disproportionality analysis in pharmacovigilance signal detection.

Pharmacoepidemiol Drug Saf. 2019 Mar;28(3):370-376. doi: 10.1002/pds.4613. Epub 2018 Jul 10.

From Big Data to Smart Data for Pharmacovigilance: The Role of Healthcare Databases and Other Emerging Sources.

Drug Saf. 2018 Feb;41(2):143-149. doi: 10.1007/s40264-017-0592-4.

[Role and Applicability of Spontaneous Reporting Databases in Medical Big Data].

Yakugaku Zasshi. 2021;141(2):165-168. doi: 10.1248/yakushi.20-00196-1.

[Pharmacovigilance in Germany : It is about time].

Internist (Berl). 2016 Jun;57(6):616-23. doi: 10.1007/s00108-016-0068-0.

Safety Concerns Reported by Patients Identified in a Collaborative Signal Detection Workshop using VigiBase: Results and Reflections from Lareb and Uppsala Monitoring Centre.

Drug Saf. 2018 Feb;41(2):203-212. doi: 10.1007/s40264-017-0594-2.

A reference standard for evaluation of methods for drug safety signal detection using electronic healthcare record databases.

Drug Saf. 2013 Jan;36(1):13-23. doi: 10.1007/s40264-012-0002-x.

引用本文的文献

Perspective review: Will generative AI make common data models obsolete in future analyses of distributed data networks?

Ther Adv Drug Saf. 2025 Apr 21;16:20420986251332743. doi: 10.1177/20420986251332743. eCollection 2025.

Interplay of Spontaneous Reporting and Longitudinal Healthcare Databases for Signal Management: Position Statement from the Real-World Evidence and Big Data Special Interest Group of the International Society of Pharmacovigilance.

Drug Saf. 2025 Apr 13. doi: 10.1007/s40264-025-01548-3.

Characterizing Public Sentiments and Drug Interactions in the COVID-19 Pandemic Using Social Media: Natural Language Processing and Network Analysis.

J Med Internet Res. 2025 Mar 5;27:e63755. doi: 10.2196/63755.

Network Analysis and Machine Learning for Signal Detection and Prioritization Using Electronic Healthcare Records and Administrative Databases: A Proof of Concept in Drug-Induced Acute Myocardial Infarction.

Drug Saf. 2025 May;48(5):513-526. doi: 10.1007/s40264-025-01515-y. Epub 2025 Feb 7.

Optimal Significance Levels and Sample Sizes for Signal Detection Methods Based on Non-constant Hazards.

Drug Saf. 2024 Nov;47(11):1149-1156. doi: 10.1007/s40264-024-01460-2. Epub 2024 Jul 9.

An innovative method to strengthen evidence for potential drug safety signals using Electronic Health Records.

J Med Syst. 2024 May 16;48(1):51. doi: 10.1007/s10916-024-02070-2.

Letter to the Editor: A Discussion About Pharmacovigilance Study Methods.

J Korean Med Sci. 2024 Apr 22;39(15):e142. doi: 10.3346/jkms.2024.39.e142.

Data-Driven Identification of Factors That Influence the Quality of Adverse Event Reports: 15-Year Interpretable Machine Learning and Time-Series Analyses of VigiBase and QUEST.

JMIR Med Inform. 2024 Apr 3;12:e49643. doi: 10.2196/49643.

Detection of novel drug-adverse drug reaction signals in rheumatoid arthritis and ankylosing spondylitis: analysis of Korean real-world biologics registry data.

Sci Rep. 2024 Feb 1;14(1):2660. doi: 10.1038/s41598-024-52822-w.

High-Throughput Computing to Automate Population-Based Studies to Detect the 30-Day Risk of Adverse Outcomes After New Outpatient Medication Use in Older Adults with Chronic Kidney Disease: A Clinical Research Protocol.

Can J Kidney Health Dis. 2024 Jan 6;11:20543581231221891. doi: 10.1177/20543581231221891. eCollection 2024.

本文引用的文献

Deconstructing the Pharmacovigilance Hype Cycle.

Clin Ther. 2018 Dec;40(12):1981-1990.e3. doi: 10.1016/j.clinthera.2018.10.021.

Web-Based Signal Detection Using Medical Forums Data in France: Comparative Analysis.

J Med Internet Res. 2018 Nov 20;20(11):e10466. doi: 10.2196/10466.

Significance of data mining in routine signal detection: Analysis based on the safety signals identified by the FDA.

Pharmacoepidemiol Drug Saf. 2018 Dec;27(12):1402-1408. doi: 10.1002/pds.4672. Epub 2018 Oct 15.

Artificial Intelligence in Public Health and Epidemiology.

Yearb Med Inform. 2018 Aug;27(1):207-210. doi: 10.1055/s-0038-1667082. Epub 2018 Aug 29.

Assessment of the Utility of Social Media for Broad-Ranging Statistical Signal Detection in Pharmacovigilance: Results from the WEB-RADR Project.

Drug Saf. 2018 Dec;41(12):1355-1369. doi: 10.1007/s40264-018-0699-2.

Reuse of data sources to evaluate drug safety signals: When is it appropriate?

Pharmacoepidemiol Drug Saf. 2018 Jun;27(6):567-569. doi: 10.1002/pds.4442. Epub 2018 Apr 27.

Time Series Disturbance Detection for Hypothesis-Free Signal Detection in Longitudinal Observational Databases.

Drug Saf. 2018 Jun;41(6):565-577. doi: 10.1007/s40264-018-0640-8.

Signal Detection for Recently Approved Products: Adapting and Evaluating Self-Controlled Case Series Method Using a US Claims and UK Electronic Medical Records Database.

Drug Saf. 2018 May;41(5):523-536. doi: 10.1007/s40264-017-0626-y.

The hope, hype and reality of Big Data for pharmacovigilance.

Ther Adv Drug Saf. 2018 Jan;9(1):5-11. doi: 10.1177/2042098617736422. Epub 2017 Oct 31.

An Automated System Combining Safety Signal Detection and Prioritization from Healthcare Databases: A Pilot Study.

Drug Saf. 2018 Apr;41(4):377-387. doi: 10.1007/s40264-017-0618-y.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Hypothesis-free signal detection in healthcare databases: finding its value for pharmacovigilance.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献